Widad Group: Positive response from phase one of clinical trials for Vaxart’s oral Covid-19 vaccine
KUALA LUMPUR (Feb 8): Widad Group Bhd, which is collaborating with Rinani Dynamic Sdn Bhd to distribute an oral-based (tablet) Covid-19 vaccine developed by Vaxart Inc in Malaysia, said phase one of the clinical trial has achieved a positive response.